Between February 18, 2025 and August 18, 2025, Hetalox Spółka z o.o. carried out a project co-financed from European Funds - Startup Booster for Social Impact.

Between February 18, 2025 and August 18, 2025, Hetalox Spółka z o.o. carried out a project co-financed from European Funds - Startup Booster for Social Impact.

Project objectives:

To develop an innovative platform for brain MRI analysis that supports monitoring the progression of neurodegenerative and demyelinating diseases. Hetalox will conduct pilot studies to validate the platform's effectiveness in clinical settings, in collaboration with mentors from the Startup Booster for Social Impact program and the investment fund 24Ventures.